Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK7580 human mass balance and absolute bioavailability study in healthy men
NL-OMON41144Active, not recruiting
- Sponsor
- Kyowa Kirin
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ASP7991 in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Kyowa Kirin. Primary endpoints: Part 1 plasma concentrations of KHK7580, Part 1 total radioactivity in plasma, whole blood, urine, and feces and 5 more. Started Aug 2014; status: active, not recruiting.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NL-OMON41144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41144.